KCL develops rapid method for antibiotic discovery against AMR

pmlive.com

Researchers at King’s College London have developed a rapid method for creating cyclic peptides, crucial in antibiotic discovery to combat antimicrobial resistance (AMR). AMR is a top ten global health threat, with TB causing 1.3 million deaths in 2022. The new method enables quick cyclic peptide production, showing promise against Mycobacterium tuberculosis. This breakthrough could lead to developing new antibiotics and other therapeutic agents.


With a significance score of 4.7, this news ranks in the top 1.8% of today's 24452 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers: